Information PortalData PortalKnowledge Portal

Data Matrix

Tools & Workflows

Documentation

2087.78 (Glytoucan)

Id:c94a6726-a4da-54b8-ac7b-6797a3462b52

Glytoucan:G69905CP

Results found

Linked to

	Label	Description
	2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G14156JX-GLYCOSEQ00162944 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G93906VI-GLYCOSEQ00016940 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G65239SF-GLYCOSEQ00121448 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G93906VI-GLYCOSEQ00016943 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 has canonical residue n-glycan b-d-glcpnac 7 Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G78813BX-GLYCOSEQ00074509 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen
	2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000085 CUI Knowledge Graph Assertion (Entity type)	A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G14156JX-GLYCOSEQ00162944 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000004 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G93906VI-GLYCOSEQ00016940 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G65239SF-GLYCOSEQ00121448 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000005 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000007 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G93906VI-GLYCOSEQ00016943 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has canonical residue n-glycan b-d-glcpnac 7

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 has glycosequence GLYGEN.GLYCOSEQUENCE:G78813BX-GLYCOSEQ00074509 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

Knowledge Graph Assertion

2087.78 synthesized by GLYCOSYLTRANSFERASE.REACTION:RXN00000085 CUI

Knowledge Graph Assertion (Entity type)

A Knowledge Graph Assertion from GlyGen

DISPLAY PER PAGE

Consortium

Community

Resources

@CFDE Workbench 2025

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

Consortium

Community

Resources

The CFDE Workbench is actively being developed and maintained by the CFDE Data Resource Center (DRC).The DRC is funded by OT2OD036435 from the Common Fund at the National Institutes of Health.

@CFDE Workbench 2025

This repository is under review for potential modification in compliance with Administration directives.